STOCK TITAN

Ecovyst Announces Term Loan Amendment and Increase

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Negative)
Tags

Ecovyst (NYSE: ECVT) plans to issue a $100 million Term Loan B add-on to help finance its pending acquisition of the Calabrian sulfur dioxide and sulfur derivatives business from INEOS Enterprises. The add-on is expected to be co-terminus with Ecovyst's existing $397 million Term Loan B due June 2031. The Calabrian acquisition is targeted to close by the end of the second quarter 2026, funded with the new term loan and cash on the balance sheet. Ecovyst expects its combined net debt leverage ratio to be approximately 2x at transaction close.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • $100 million Term Loan B add-on planned to finance Calabrian acquisition
  • New add-on expected to be co-terminus with $397 million Term Loan B due June 2031
  • Company expects combined net debt leverage ratio of approximately 2x at close

Negative

  • Planned $100 million Term Loan B add-on will increase overall debt levels

Key Figures

Term Loan B add-on: $100 million Existing Term Loan B: $397 million Net debt leverage ratio: 2x +1 more
4 metrics
Term Loan B add-on $100 million Fungible Term Loan B issuance to finance Calabrian acquisition
Existing Term Loan B $397 million Existing Term Loan B maturing June 2031, co-terminous with add-on
Net debt leverage ratio 2x Expected combined net debt leverage at close of Calabrian transaction
Targeted closing End of Q2 2026 Expected closing timing for Calabrian acquisition

Market Reality Check

Price: $14.42 Vol: Volume 2,420,606 is 1.35x...
normal vol
$14.42 Last Close
Volume Volume 2,420,606 is 1.35x the 20-day average, indicating elevated interest ahead of the financing news. normal
Technical Shares at $14.14 trade above the 200-day MA $10.24 and about 5.35% below the 52-week high.

Peers on Argus

ECVT gained 1.22% with mixed peer moves: SCL, ODC and KRO were positive, while M...

ECVT gained 1.22% with mixed peer moves: SCL, ODC and KRO were positive, while MATV and CLMT declined, suggesting a stock-specific response rather than a broad specialty chemicals move.

Historical Context

5 past events · Latest: May 05 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
May 05 Q1 2026 earnings Positive +4.3% Strong Q1 growth, higher Adjusted EBITDA and raised 2026 guidance.
May 01 Calabrian acquisition Positive +1.3% Agreement to acquire Calabrian sulfur derivatives business for growth and synergies.
Apr 20 Earnings call setup Neutral -1.0% Announcement of Q1 2026 earnings conference call and webcast timing.
Feb 26 FY 2025 earnings Positive +1.1% Q4 and full-year results, leverage reduction and 2026 guidance provided.
Feb 13 Earnings call setup Neutral +1.4% Scheduling of Q4 2025 earnings conference call and webcast.
Pattern Detected

Positive fundamental updates (earnings strength and the Calabrian acquisition) have recently been followed by modest share price gains, while neutral scheduling headlines have seen small, mixed reactions.

Recent Company History

Over the past few months, Ecovyst has reported stronger results and pursued sulfur-based expansion. On Feb 26, Q4 2025 earnings detailed higher sales and reduced net debt leverage. A Q1 2026 earnings call was set on Apr 20, followed by full Q4 and Q1 results on Feb 26 and May 5 with guidance increases. On May 1, Ecovyst announced the Calabrian acquisition, targeting closing by end of Q2 2026. Today’s term loan add-on directly supports that same acquisition strategy.

Market Pulse Summary

This announcement details Ecovyst’s plan to issue a $100 million fungible Term Loan B add-on, co-ter...
Analysis

This announcement details Ecovyst’s plan to issue a $100 million fungible Term Loan B add-on, co-terminous with its existing $397 million Term Loan B due June 2031, to help fund the Calabrian acquisition. Management expects combined net debt leverage of about 2x at closing. Investors may contextualize this against recent earnings strength and prior guidance, monitoring leverage trends, closing progress by end of Q2 2026, and integration of the Calabrian assets.

Key Terms

term loan b, fungible, net debt leverage ratio
3 terms
term loan b financial
"intends to issue a $100 million fungible Term Loan B add-on"
A Term Loan B (TLB) is a large, syndicated loan made to a company that is typically sold to institutional investors rather than held by banks; think of it as a long-term mortgage from a group of investors with higher interest and smaller early payments. It matters to investors because it changes a company’s debt cost, repayment schedule and credit risk—factors that affect profit, cash flow and the market value of both the company’s equity and its traded debt.
fungible financial
"intends to issue a $100 million fungible Term Loan B add-on"
Fungible describes an asset that is interchangeable with another of the same kind because each unit holds the same value and function. For investors this matters because fungible assets are easier to trade, price, and store—think of cash or grains where one unit can replace another, unlike a unique artwork or a signed collectible which may be worth more or less depending on provenance. Fungibility affects liquidity, market efficiency, and how assets are settled or regulated.
net debt leverage ratio financial
"We expect our combined net debt leverage ratio would be approximately 2x"
Net debt leverage ratio measures how many years of a company’s core earnings would be needed to pay off its debt after accounting for cash on hand, calculated by dividing net debt (total debt minus cash) by annual operating earnings. Investors use it like a household debt-to-income check: a lower number means the company is in a stronger position to handle obligations and take risks, while a higher number signals greater financial strain and vulnerability to shocks.

AI-generated analysis. Not financial advice.

WAYNE, Pa., May 11, 2026 /PRNewswire/ -- Ecovyst Inc. (NYSE: ECVT) ("Ecovyst" or the "Company"), a leading provider of virgin sulfuric acid and regenerated sulfuric acid products and services, today announced that it intends to issue a $100 million fungible Term Loan B add-on to finance its pending acquisition of the Calabrian sulfur dioxide and related sulfur derivatives business from INEOS Enterprises, which is targeted to close by the end of the second quarter 2026, along with cash on the balance sheet. The add-on is expected to be co-terminus with the Company's existing $397 million Term Loan B due June 2031.

"We believe this amendment to our Term Loan Facility, along with cash on hand, will provide the optimal financing structure for the Calabrian acquisition, expected to close at the end of the second quarter," commented Mike Feehan, Ecovyst's Chief Financial Officer. "We expect our combined net debt leverage ratio would be approximately 2x at close of the transaction."

About Ecovyst

Ecovyst Inc. and subsidiaries is a leading provider of virgin sulfuric acid and regenerated sulfuric acid products and services. We believe that our products and services contribute to improving the sustainability of the environment.

We are a leading provider of sulfuric acid recycling to the North American refining industry for the production of alkylate, an essential gasoline component for lowering vapor pressure and increasing octane to meet stringent gasoline specifications and fuel efficiency standards. We are also a leading North American producer of high quality and high strength virgin sulfuric acid for industrial and mining applications. We also provide chemical waste handling and treatment services, as well as ex-situ catalyst activation services for the refining and petrochemical industry.

For more information, see our website at https://www.ecovyst.com.

Note on Forward-Looking Statements

Some of the information contained in this press release constitutes "forward-looking statements." Forward-looking statements can be identified by words such as "anticipates," "intends," "plans," "seeks," "believes," "estimates," "expects," "projects," "aims" and similar references to future periods. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Examples of forward-looking statements include, but are not limited to, our intention to issue a term loan add-on to finance our pending acquisition of the Calabrian sulfur dioxide and related sulfur derivatives business from INEOS Enterprises, the anticipated terms of the term loan financing, the anticipated benefits and timing of the closing of the INEOS Enterprises transaction and term loan financing, and our anticipated financial position following consummation of the INEOS Enterprises transaction and term loan financing, including our combined net debt leverage ratio. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you, therefore, against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: our ability to successfully close the term loan financing, the possibility that the conditions to the closing of the INEOS Enterprises transaction or term loan financing are not satisfied; the occurrence of any event, change or other circumstance that could give rise to a right to terminate the transaction with INEOS Enterprises; unexpected costs, liabilities or delays in connection with the INEOS Enterprises transaction and term loan financing; legal proceedings initiated in connection with the INEOS Enterprises transaction; risks related to the integration of the acquired Calabrian sulfur dioxide and related sulfur derivatives business of INEOS Enterprises; regional, national or global political, economic, business, competitive, market and regulatory conditions, including the enactment, schedule and impact of tariffs and trade disputes; currency exchange rates; the effects of inflation; and other factors, including those described in the sections titled "Risk Factors" and "Management's Discussion & Analysis of Financial Condition and Results of Operations" in our filings with the SEC, which are available on the SEC's website at www.sec.gov. These forward-looking statements speak only as of the date of this release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law.

For more information:
Gene Shiels – Director of Investor Relations
(484) 617 1225
gene.shiels@ecovyst.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ecovyst-announces-term-loan-amendment-and-increase-302768166.html

SOURCE Ecovyst Inc.

FAQ

What financing did Ecovyst (NYSE: ECVT) announce for the Calabrian acquisition on May 11, 2026?

Ecovyst plans a $100 million fungible Term Loan B add-on to help finance the Calabrian acquisition. According to Ecovyst, this financing will be used alongside cash on the balance sheet to fund the pending transaction.

How will Ecovyst fund the acquisition of the Calabrian sulfur dioxide business from INEOS Enterprises?

Ecovyst intends to fund the Calabrian acquisition with a $100 million Term Loan B add-on and cash on hand. According to Ecovyst, the loan add-on will be fungible with its existing Term Loan B facility.

When is Ecovyst’s Calabrian acquisition expected to close and what is the impact on leverage?

The Calabrian acquisition is targeted to close by the end of second quarter 2026. According to Ecovyst, it expects its combined net debt leverage ratio to be approximately 2x at the close of the transaction.

What is the maturity profile of Ecovyst’s new Term Loan B add-on for the Calabrian deal?

The $100 million Term Loan B add-on is expected to be co-terminus with Ecovyst’s existing Term Loan B. According to Ecovyst, the existing $397 million Term Loan B matures in June 2031, aligning the new debt with this maturity.

What does Ecovyst’s planned Term Loan B amendment mean for ECVT shareholders?

The planned $100 million Term Loan B add-on would increase debt to finance the Calabrian acquisition. According to Ecovyst, the structure aims to optimize financing while keeping combined net debt leverage around 2x at transaction close.

Why does Ecovyst believe the new Term Loan B add-on is an optimal financing structure?

Ecovyst believes the Term Loan B amendment, combined with cash on hand, provides an optimal structure for the Calabrian acquisition. According to Ecovyst, this approach supports the transaction while targeting combined net debt leverage of about 2x at closing.